Nasdaq

Medtronic receives FDA clearance for expanded indication of LINQ II™ insertable cardiac monitor for use in pediatric patients ages 2 and older

The LINQ II ICM is the first continuous, long-term cardiac monitor cleared by FDA for the pediatric patient population The LINQ II system is a small (one-third the size of a AAA battery), wireless ICM ...
Star Tribune

Medtronic secures FDA clearance for pediatric use of implantable cardiac monitor

Medtronic this week received regulatory approval for use of an implantable cardiac monitor in pediatric patients, giving doctors and parents greater peace of mind about the device's safety. On Tuesday ...
Nasdaq

Medtronic: FDA Approves Expanded Indication For LINQ II ICM For Use In Pediatric Patient Population

(RTTNews) - Medtronic plc (MDT) announced the LINQ II Insertable Cardiac Monitor system is the first-and-only ICM to receive 510(k) clearance by the FDA for use in pediatric patients over the age of 2 ...
FOX10 News

FDA expands uses for insertable cardiac monitor to children

MOBILE, Ala. (WALA) -The FDA recently expanded use for the LINQ II™ insertable cardiac monitor (ICM) to patients ages 2 years and older who have heart rhythm issues. About one-third the size of a AAA ...
MedCity News

Using AI to reduce false alerts for patients with heart monitoring devices to detect cardiac arrhythmias

Medtronic developed a way to reduce false alerts through its AccuRhythm™ AI algorithms. The algorithm is applied through cloud-based updates to all LINQ II™ Insertable Cardiac Monitors (ICMs) and ...